Dogwood Therapeutics Statistics
Total Valuation
DWTX has a market cap or net worth of $7.99 million. The enterprise value is $8.73 million.
Important Dates
The last earnings date was Monday, March 31, 2025.
| Earnings Date | Mar 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DWTX has 1.91 million shares outstanding. The number of shares has increased by 36.84% in one year.
| Current Share Class | 1.91M |
| Shares Outstanding | 1.91M |
| Shares Change (YoY) | +36.84% |
| Shares Change (QoQ) | +18.03% |
| Owned by Insiders (%) | 3.91% |
| Owned by Institutions (%) | 2.05% |
| Float | 1.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.12 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.21, with a Debt / Equity ratio of 0.24.
| Current Ratio | 5.21 |
| Quick Ratio | 4.67 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -132.63 |
Financial Efficiency
Return on equity (ROE) is -36.28% and return on invested capital (ROIC) is -18.27%.
| Return on Equity (ROE) | -36.28% |
| Return on Assets (ROA) | -15.52% |
| Return on Invested Capital (ROIC) | -18.27% |
| Return on Capital Employed (ROCE) | -13.42% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.22M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -503 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.04% in the last 52 weeks. The beta is 2.01, so DWTX's price volatility has been higher than the market average.
| Beta (5Y) | 2.01 |
| 52-Week Price Change | -69.04% |
| 50-Day Moving Average | 7.76 |
| 200-Day Moving Average | 5.09 |
| Relative Strength Index (RSI) | 38.53 |
| Average Volume (20 Days) | 3,069,859 |
Short Selling Information
The latest short interest is 193,797, so 10.14% of the outstanding shares have been sold short.
| Short Interest | 193,797 |
| Short Previous Month | 26,380 |
| Short % of Shares Out | 10.14% |
| Short % of Float | 12.46% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.23M |
| Pretax Income | n/a |
| Net Income | -12.86M |
| EBITDA | n/a |
| EBIT | -12.23M |
| Earnings Per Share (EPS) | -$12.52 |
Full Income StatementBalance Sheet
The company has $14.85 million in cash and $15.59 million in debt, giving a net cash position of -$737,709 or -$0.39 per share.
| Cash & Cash Equivalents | 14.85M |
| Total Debt | 15.59M |
| Net Cash | -737,709 |
| Net Cash Per Share | -$0.39 |
| Equity (Book Value) | 64.28M |
| Book Value Per Share | -5.30 |
| Working Capital | 13.37M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |